ekos ultrasound infusion system

The Ekos Ultrasound Infusion System is a catheter-based device that uses ultrasound to enhance the delivery of thrombolytic agents directly to thrombi. It is intended for use in the treatment of thrombotic conditions, particularly when systemic thrombolysis is not an option.

Commonly used in the management of acute pulmonary embolism and deep vein thrombosis, the device is particularly beneficial in patients who cannot undergo systemic thrombolysis. It is employed in scenarios requiring targeted thrombolysis to improve patient outcomes.

The available literature includes 15 studies, comprising randomized controlled trials, prospective and retrospective analyses, and case series, conducted between 2021 and 2023. These studies evaluate the device's efficacy and safety in various thrombotic conditions.

Published studies report that the Ekos Ultrasound Infusion System effectively reduces pulmonary artery pressures and improves cardiac index in patients with pulmonary embolism. One study noted a significant reduction in systolic and mean pulmonary artery pressures post-treatment. The device has shown promise in reversing right ventricular dysfunction.

Reported complications include minor bleeding at the access site, with no intracranial hemorrhages observed. The studies indicate a favorable safety profile, with no deaths or therapy intensifications reported within 180 days post-treatment.

Current evidence is limited by small sample sizes and the need for further research to establish optimal dosing regimens. Long-term outcomes and comparisons with alternative therapies require additional investigation.